Oxazol/ thiazol-derivatives activators of the hPPAR-alpha receptor

Details for Australian Patent Application No. 2002317765 (hide)

Owner Glaxo Group Limited

Inventors Gellibert, Francoise Jeanne

Agent Phillips Ormonde Fitzpatrick

Pub. Number AU-B-2002317765

PCT Number PCT/EP02/05886

PCT Pub. Number WO2002/096895

Priority 0113231.5 31.05.01 GB

Filing date 29 May 2002

Wipo publication date 9 December 2002

Acceptance publication date 3 February 2005

International Classifications

C07D 277/56 Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings

A61K 031/42 - Oxazoles

A61K 031/425 - Thiazoles

Event Publications

9 January 2003 Complete Application Filed

  Priority application(s): 0113231.5 31.05.01 GB

8 May 2003 Application Open to Public Inspection

  Published as AU-B-2002317765

3 February 2005 Application Accepted

  Published as AU-B-2002317765

2 June 2005 Standard Patent Sealed

24 December 2009 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This patent ceased under section 143(a), or Expired. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2002317766-COPOLYMERS OF $G(A)-OLEFINS AND OF FUNCTIONAL MONOMERS, THEIR PRODUCTION AND THE USE THEREOF

2002317764-Process for preparing a thialzole PPARligand and polymorphs thereof